NA
TWST icon

Navellier & Associates’s Twist Bioscience TWST Stock Holding History

Navellier & Associates’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,789
Closed -$216K – 351
2021
Q4 		$216K Sell
2,789
-1,389
-33% -$143K 0.03% 296
2021
Q3 		$447K Sell
4,178
-65
-2% -$7.44K 0.07% 210
2021
Q2 		$565K Sell
4,243
-29
-0.7% -$3.37K 0.09% 185
2021
Q1 		$529K Buy
4,272
+39
+0.9% +$5.92K 0.1% 171
2020
Q4 		$598K Buy
+4,233
New +$470K 0.11% 147

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Navellier & Associates's TWST Position: Q1 2022 in Review

Navellier & Associates sold out of Twist Bioscience (TWST) in Q1 2022, closing a stake of 2,789 shares — an estimated $216K sold.

Navellier & Associates first reported a position in TWST in Q4 2020 and held it in 5 quarters. The position peaked at $598K in Q4 2020. 212 funds tracked by Wall St. Rank hold TWST as of Q1 2022.

  • Navellier & Associates reported no remaining Twist Bioscience position as of Q1 2022 after selling out during the quarter.
  • Navellier & Associates sold 2,789 Twist Bioscience shares in Q1 2022, an estimated $216K.
  • Navellier & Associates first reported a position in Twist Bioscience in Q4 2020 and held it in 5 quarters.
  • Navellier & Associates's Twist Bioscience position peaked at $598K in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2022.

Based on Navellier & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.